Skip to content
10-Q

Quarterly Report

Bio-AMD Inc.

0001185185-14-003126

← back to feed
Filed
Nov 14, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2014 · Nov 6, 2014 44.53M sh
Stockholders Equity Q3 2014 · Sep 30, 2014 $1.14M
Stockholders Equity Q3 2014 · Dec 31, 2013 $2M
Current Liabilities Q3 2014 · Sep 30, 2014 $37.98K
Current Liabilities Q3 2014 · Dec 31, 2013 $40K
Total Liabilities Q3 2014 · Sep 30, 2014 $37.98K
Total Liabilities Q3 2014 · Dec 31, 2013 $40K
Current Assets Q3 2014 · Sep 30, 2014 $1.07M
Current Assets Q3 2014 · Dec 31, 2013 $1.95M
Total Assets Q3 2014 · Dec 31, 2013 $2.04M
Total Assets Q3 2014 · Sep 30, 2013 $2.19M
Shares Diluted Q3 2014 · Sep 30, 2013 44.53M sh
Shares Diluted Q3 2014 · Sep 30, 2013 44.53M sh
Capex Q3 2014 · Sep 30, 2013 $0
Capex Q3 2014 · Sep 30, 2013 $410
Cash And Equivalents Q3 2014 · Sep 30, 2013 $2.08M
Cash And Equivalents Q3 2014 · Dec 31, 2012 $2.94M
Eps Diluted Q3 2014 · Sep 30, 2013 −$0.01
Eps Diluted Q3 2014 · Sep 30, 2013 −$0.02
Eps Basic Q3 2014 · Sep 30, 2013 −$0.01
Eps Basic Q3 2014 · Sep 30, 2013 −$0.02
Sga Expense Q3 2014 · Sep 30, 2013 $266.99K
Sga Expense Q3 2014 · Sep 30, 2013 $857.35K
Net Income Q3 2014 · Sep 30, 2013 −$265.19K
Net Income Q3 2014 · Sep 30, 2013 −$781.71K
Operating Income Q3 2014 · Sep 30, 2013 −$266.99K
Operating Income Q3 2014 · Sep 30, 2013 −$857.35K
Revenue Q3 2014 · Sep 30, 2013 $0
Revenue Q3 2014 · Sep 30, 2013 $0